Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases
- 1 December 2018
- Vol. 50 (7) , 703-710
Abstract
No abstract availableKeywords
Funding Information
- Deutschen Konsortium für Translationale Krebsforschung
This publication has 34 references indexed in Scilit:
- Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in MelanomaCancer Discovery, 2013
- Oncogenic NRAS signaling differentially regulates survival and proliferation in melanomaNature Medicine, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- KIT as a Therapeutic Target in Metastatic MelanomaJAMA, 2011
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- A new understanding in the epidemiology of melanomaExpert Review of Anticancer Therapy, 2010
- Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human CancerCancer Research, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- BRAF Signaling and Targeted Therapies in MelanomaHematology/Oncology Clinics of North America, 2009
- Melanoma biology and new targeted therapyNature, 2007